Web Desc
Host and the Environment in IBD: Scientific Advances Leading to New Therapeutics
Organizer(s): Gary D. Wu, Scott Snapper, Judy H. Cho and Aida Habtezion
Date: January 13 - 17, 2019
Location: Sagebrush Inn & Suites, Taos, NM, USA
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc., Janssen R&D: Pharmaceutical Companies of Johnson & Johnson, Takeda Pharmaceutical Company Limited and Theravance Biopharma
Summary of Meeting:
Inflammatory bowel diseases (IBD), which afflict millions of patients, are rapidly increasing in incidence world-wide in parallel with industrialization. Pathogenesis involves both host genetic as well environmental factors, with the most currently utilized therapeutics focusing on long-term host immunosuppression. Despite tremendous advances in our understanding of IBD genetics, the mucosal immune system, and environmental factors such as the gut microbiome, currently available therapeutic modalities for IBD remain suboptimal. The overall goal of this conference is to bring together world-class investigators and clinicians to discuss the latest scientific knowledge relevant to the pathogenesis of IBD and facilitate an interactive discussion to accelerate development of new opportunities to prevent and/or treat IBD. The specific aims of this conference are to: 1) Bring together a combination of clinical and basic investigators from both academia and industry to facilitate cross-disciplinary discussions focused on IBD; 2) Identify both opportunities and gaps in current knowledge of the pathogenesis of IBD important for the development of new diagnostics and therapeutics; and 3) Create a multidisciplinary environment that will inspire both young and established investigators by highlighting currently available opportunities in IBD research. The anticipated outcome will be a better understanding of the advances and challenges in developing new therapies for patients with IBD.
Scholarship Deadline: October 4 2018
Discounted Abstract Deadline: October 4 2018
Abstract Deadline: October 16 2018
Discounted Registration Deadline: November 13 2018
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Boehringer Ingelheim Pharmaceuticals, Inc.Janssen R&D: Pharmaceutical Companies of Johnson & JohnsonTakeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company LimitedTheravance Biopharma
We gratefully acknowledge additional support for this conference from:
Kenneth Rainin Foundation
Keystone Symposia thanks the following Patrons for their support of $5,000 - $9,999.
Kenneth Rainin Foundation
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1 R13 DK118917-01
Funding for this conference was made possible (in part) by 1 R13 DK118917-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, January 13 | 4:00PM - 8:00PM
Arrival and Registration
Room: Sagebrush Lobby & Cantina


Sunday, January 13 | 6:00PM - 8:00PM
Welcome Mixer
Room: Sagebrush Lobby & Cantina
No registration fees are used to fund alcohol served at this function.

Monday, January 14 | 7:00AM - 8:00AM
Breakfast
Room: Sagebrush Lobby & Cantina


Monday, January 14 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Chamisa Ballroom 1

Speaker 1 of 2
* Gary D. Wu, University of Pennsylvania, USA

Monday, January 14 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Chamisa Ballroom 1

Speaker 2 of 2
Fiona M. Powrie, University of Oxford, UK
Gut Reactions: Immune Pathways in the Intestine in Health and Disease

Monday, January 14 | 9:00AM - 11:30AM
Clinical Considerations of IBD-What's the Goal?
Room: Chamisa Ballroom 1

Speaker 1 of 7
* Gary D. Wu, University of Pennsylvania, USA

Monday, January 14 | 9:00AM - 11:30AM
Clinical Considerations of IBD-What's the Goal?
Room: Chamisa Ballroom 1

Speaker 2 of 7
Gilaad Kaplan, University of Calgary, Canada
Clinical Epidemiology: The Rising Incidence of IBD Associated with Industrialization

Monday, January 14 | 9:00AM - 11:30AM
Clinical Considerations of IBD-What's the Goal?
Room: Chamisa Ballroom 1


Coffee Break

Monday, January 14 | 9:00AM - 11:30AM
Clinical Considerations of IBD-What's the Goal?
Room: Chamisa Ballroom 1

Speaker 4 of 7
Dermot P. B. McGovern, Cedars Sinai Medical Center, USA
Using Genomics to Explain the Clinical Heterogeneity of IBD

Monday, January 14 | 9:00AM - 11:30AM
Clinical Considerations of IBD-What's the Goal?
Room: Chamisa Ballroom 1

Speaker 5 of 7
Séverine Vermeire, KU Leuven, Belgium
Current and Future Therapeutics with Companion Diagnostics in IBD

Monday, January 14 | 9:00AM - 11:30AM
Clinical Considerations of IBD-What's the Goal?
Room: Chamisa Ballroom 1

Speaker 6 of 7
John Y. Kao, University of Michigan, USA
Short Talk: Congenital Hypothyroidism Is a Risk Factor for Inflammatory Bowel Disease

Monday, January 14 | 9:00AM - 11:30AM
Clinical Considerations of IBD-What's the Goal?
Room: Chamisa Ballroom 1

Speaker 7 of 7
Angela Mo, Georgia Institute of Technology, USA
Short Talk: An Expression Based Risk Score for Prediction of Disease Course in Pediatric Ulcerative Colitis

Monday, January 14 | 11:30AM - 5:00PM
On Own for Lunch


Monday, January 14 | 11:30AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Monday, January 14 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Monday, January 14 | 2:30PM - 4:30PM
Workshop 1: Host Factors in IBD
Room: Chamisa Ballroom 1

Speaker 1 of 7
* Scott Snapper, Children`s Hospital Boston, USA

Monday, January 14 | 2:30PM - 4:30PM
Workshop 1: Host Factors in IBD
Room: Chamisa Ballroom 1

Speaker 2 of 7
* Aida Habtezion, Stanford School of Medicine, USA

Monday, January 14 | 2:30PM - 4:30PM
Workshop 1: Host Factors in IBD
Room: Chamisa Ballroom 1

Speaker 3 of 7
June-Yong Lee, New York University School of Medicine, USA
Pathogenic Role of Serum Amyloid A Proteins in Th17-Mediated Chronic Inflammation

Monday, January 14 | 2:30PM - 4:30PM
Workshop 1: Host Factors in IBD
Room: Chamisa Ballroom 1

Speaker 4 of 7
Phi Luong, Boston Children's Hospital, USA
C1ORF106/INAVA-ARNO Complexes Bridge Mucosal Barrier Function with Inflammatory Signaling

Monday, January 14 | 2:30PM - 4:30PM
Workshop 1: Host Factors in IBD
Room: Chamisa Ballroom 1

Speaker 5 of 7
Kairui Mao, NIAID, National Institutes of Health, USA
Sequential Innate and Adaptive Immunity Establishes Non-Inflammatory Gut Commensalism and Physiologic Host Lipid Metabolism

Monday, January 14 | 2:30PM - 4:30PM
Workshop 1: Host Factors in IBD
Room: Chamisa Ballroom 1

Speaker 6 of 7
Vu Ngo, Georgia State University, USA
IL-36 Receptor Signaling Orchestrates IL-23-Mediated Gut Barrier Repair and Defense

Monday, January 14 | 2:30PM - 4:30PM
Workshop 1: Host Factors in IBD
Room: Chamisa Ballroom 1

Speaker 7 of 7
Samuel Rubin, Stanford University School of Medicine, USA
Mass Cytometry Reveals Systemic and Local Immune Signatures that Distinguish Inflammatory Bowel Diseases

Monday, January 14 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Monday, January 14 | 5:00PM - 7:00PM
Advances in the Genetics of IBD
Room: Chamisa Ballroom 1

Speaker 1 of 5
* Carl Anderson, Sanger Institute, UK

Monday, January 14 | 5:00PM - 7:00PM
Advances in the Genetics of IBD
Room: Chamisa Ballroom 1

Speaker 2 of 5
Judy H. Cho, Icahn School of Medicine at Mount Sinai, USA
Precision IBD and Population Differences in Innate Immunity

Monday, January 14 | 5:00PM - 7:00PM
Advances in the Genetics of IBD
Room: Chamisa Ballroom 1

Speaker 3 of 5
Jeffrey Barrett, Genomics plc, UK
Using Human Genetics to Give the Right IBD Patient the Right Drug

Monday, January 14 | 5:00PM - 7:00PM
Advances in the Genetics of IBD
Room: Chamisa Ballroom 1

Speaker 4 of 5
Ramnik Xavier, Massachusetts General Hospital, USA
From IBD-Associated Genotypes to Altered Cellular and Organismal Function

Monday, January 14 | 5:00PM - 7:00PM
Advances in the Genetics of IBD
Room: Chamisa Ballroom 1

Speaker 5 of 5
Olga Sazonova, 23andMe, Inc., USA
Short Talk: Polygenic Modeling Identifies Individuals whose Genetic Risk for IBD Is Comparable to Positive Family History

Monday, January 14 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2
No registration fees are used to fund alcohol served at this function.

Monday, January 14 | 7:30PM - 10:00PM
Poster Session 1
Room: Chamisa Ballroom 2


Tuesday, January 15 | 7:00AM - 8:00AM
Breakfast
Room: Sagebrush Lobby & Cantina


Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1

Speaker 1 of 9
* Aida Habtezion, Stanford School of Medicine, USA

Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1

Speaker 2 of 9
Richard S. Blumberg, Brigham and Women's Hospital, USA
FcRn Defines Immune Responses to IgG-Containing Immune Complexes

Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1

Speaker 3 of 9
Clara Abraham, Yale University, USA
Modulation of Innate Immune Responses by IBD-associated Genes

Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1


Coffee Break

Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1

Speaker 5 of 9
Gérard Eberl, Institut Pasteur, France
Type 3 Innate Lymphoid Cells Facing Dietary and Microbial Perturbations

Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1

Speaker 6 of 9
Gabriel Nuñez, University of Michigan, USA
Specific NOD2-Microbiota Interactions Drive Crohn's-Like Disease

Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1

Speaker 7 of 9
Randy S. Longman, Weill Cornell Medical College, USA
Short Talk: Intestinal Mononuclear Phagocyte-Derived TL1A Is a Central Regulator of Group 3 Innate Lymphoid Cells in Inflammatory Bowel Disease

Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1

Speaker 8 of 9
William McAlpine, University of Texas Southwestern, USA
Short Talk: Loss of SMCR8 or WDR41 Results in Immune Dysregulation and Colitis Susceptibility

Tuesday, January 15 | 8:00AM - 11:15AM
The Mucosal Immune System in IBD-Innate Immunity
Room: Chamisa Ballroom 1

Speaker 9 of 9
Naresh Singh Redhu, Boston Children's Hospital, USA
Short Talk: Deletion of STAT1 Ameliorates Early-Onset Colitis in IL10R-deficient Mice

Tuesday, January 15 | 11:15AM - 5:00PM
On Own for Lunch


Tuesday, January 15 | 11:15AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Tuesday, January 15 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Tuesday, January 15 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Tuesday, January 15 | 5:00PM - 7:00PM
The Mucosal Immune System in IBD-Adaptive Immunity
Room: Chamisa Ballroom 1

Speaker 1 of 6
* Scott Snapper, Children`s Hospital Boston, USA

Tuesday, January 15 | 5:00PM - 7:00PM
The Mucosal Immune System in IBD-Adaptive Immunity
Room: Chamisa Ballroom 1

Speaker 2 of 6
Eoin McKinney, Cambridge University, UK
T-Cell Exhaustion, Co-Stimulation and Clinical Outcome in Autoimmunity and Infection

Tuesday, January 15 | 5:00PM - 7:00PM
The Mucosal Immune System in IBD-Adaptive Immunity
Room: Chamisa Ballroom 1

Speaker 3 of 6
Vijay K. Kuchroo, Brigham and Women's Hospital, Harvard Medical School, USA
Induction of Effector and Regulatory T Cells

Tuesday, January 15 | 5:00PM - 7:00PM
The Mucosal Immune System in IBD-Adaptive Immunity
Room: Chamisa Ballroom 1

Speaker 4 of 6
Aida Habtezion, Stanford School of Medicine, USA
Trafficking and Immune Response in IBD

Tuesday, January 15 | 5:00PM - 7:00PM
The Mucosal Immune System in IBD-Adaptive Immunity
Room: Chamisa Ballroom 1

Speaker 5 of 6
Wei Yang, University of Alabama at Birmingham, USA
Short Talk: Protein Kinase 2 (CK2) Is Required for CD4+ T Cell Function in the Pathogenesis of Colitis

Tuesday, January 15 | 5:00PM - 7:00PM
The Mucosal Immune System in IBD-Adaptive Immunity
Room: Chamisa Ballroom 1

Speaker 6 of 6
Yu Hui Kang, Boston Children's Hospital, USA
Short Talk: STAT1 Signaling Shields T Cells from NK Cell-Mediated Cytotoxicity to Enable Intestinal Inflammation

Tuesday, January 15 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2
No registration fees are used to fund alcohol served at this function.

Tuesday, January 15 | 7:30PM - 10:00PM
Poster Session 2
Room: Chamisa Ballroom 2


Wednesday, January 16 | 7:00AM - 8:00AM
Breakfast
Room: Sagebrush Lobby & Cantina


Wednesday, January 16 | 8:00AM - 11:15AM
The Environment in IBD Pathogenesis (Microbiome)
Room: Chamisa Ballroom 1

Speaker 1 of 8
Andreas J. Bäumler, University of California, Davis, USA
Healthy Guts Exclude Oxygen


Wednesday, January 16 | 8:00AM - 11:15AM
The Environment in IBD Pathogenesis (Microbiome)
Room: Chamisa Ballroom 1

Speaker 2 of 8
* June L. Round, University of Utah, USA
A Role for Fungi in IBD

Wednesday, January 16 | 8:00AM - 11:15AM
The Environment in IBD Pathogenesis (Microbiome)
Room: Chamisa Ballroom 1


Coffee Break

Wednesday, January 16 | 8:00AM - 11:15AM
The Environment in IBD Pathogenesis (Microbiome)
Room: Chamisa Ballroom 1

Speaker 4 of 8
Andrew J.S. Macpherson, University of Bern, Switzerland
Microbial Network Disturbances in Relapsing Refractory Crohn’s Disease

Wednesday, January 16 | 8:00AM - 11:15AM
The Environment in IBD Pathogenesis (Microbiome)
Room: Chamisa Ballroom 1

Speaker 5 of 8
David N. Cook, Seres Therapeutics, Inc., USA
A Novel Approach to Treating Active Ulcerative Colitis using Microbial Consortia

Wednesday, January 16 | 8:00AM - 11:15AM
The Environment in IBD Pathogenesis (Microbiome)
Room: Chamisa Ballroom 1

Speaker 6 of 8
Samantha Hsieh, Washington University School of Medicine, USA
Short Talk: Diet Modulates T Cell Immune Responses by Regulating the Expression of a Dominant Antigen from a Gut Symbiont

Wednesday, January 16 | 8:00AM - 11:15AM
The Environment in IBD Pathogenesis (Microbiome)
Room: Chamisa Ballroom 1

Speaker 7 of 8
Eric C. Martens, University of Michigan Medical School, USA
Short Talk: Combined Low Dietary Fiber and Mucus-Degrading Symbiotic Gut Bacteria Cause Lethal Colitis in IL-10 Deficient Mice

Wednesday, January 16 | 8:00AM - 11:15AM
The Environment in IBD Pathogenesis (Microbiome)
Room: Chamisa Ballroom 1

Speaker 8 of 8
Amira Metwaly, Technical University of Munich, Germany
Short Talk: Integrative Multi-Omics Identification of Biomarker Microbial Signatures

Wednesday, January 16 | 11:15AM - 5:00PM
On Own for Lunch


Wednesday, January 16 | 11:15AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Wednesday, January 16 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 1 of 10
* Judy H. Cho, Icahn School of Medicine at Mount Sinai, USA

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 2 of 10
* Gary D. Wu, University of Pennsylvania, USA

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 3 of 10
Roberta Caruso, University of Michigan, USA
Specific Host-Microbiota Interactions Drive the Development of Crohn’s Disease-Like Colitis in Mice

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 4 of 10
Benoit Chassaing, Georgia State University, USA
Dietary Emulsifiers Directly Impact Adherent and Invasive E. coli, Promoting Intestinal Inflammation

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 5 of 10
Uri Gophna, Tel Aviv University, Israel
Prolonged Antibiotic Treatment of Pouchitis Generates Broad Microbiome-Wide Resistance to Fluoroquinolones as well as Collateral Resistance

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 6 of 10
Nobuhiko Kamada, University of Michigan, USA
Adherent-Invasive Escherichia coli Employs Diet-Derived Amino Acids to Maximize its Fitness in the Inflamed Gut

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 7 of 10
Serre-Yu Wong, Mount Sinai Hospital, USA
Host Microbe and Intra-Microbiome Interactions Leading to Small Intestinal Inflammation in Nod2-/- Mice

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 8 of 10
Sungwhan F. Oh, Brigham and Women's Hospital/Harvard Medical School, USA
Structure and Immunoprotective Functions of Gut Symbiotic Glycosphingolipids: Direct Impact of the Host Diet

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 9 of 10
Hao Tran, Georgia State University, USA
Flagellin-Elicited Adaptive Immunity Suppresses Flagellated Microbiota and Vaccinates against Chronic Inflammatory Diseases

Wednesday, January 16 | 2:30PM - 4:30PM
Workshop 2: Environmental Factors in IBD
Room: Chamisa Ballroom 1

Speaker 10 of 10
Emilie Viennois, Georgia State University, USA
Fecal miRNAs, Mediators of the Host-Microbiota Interaction, Can Restore Intestinal Health

Wednesday, January 16 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Wednesday, January 16 | 5:00PM - 7:00PM
Barrier Function in IBD
Room: Chamisa Ballroom 1

Speaker 1 of 6
* Dirk Haller, Technical University of Munich, Germany

Wednesday, January 16 | 5:00PM - 7:00PM
Barrier Function in IBD
Room: Chamisa Ballroom 1

Speaker 2 of 6
Thaddeus S. Stappenbeck, Cleveland Clinic, USA
The Intestinal Epithelium in IBD

Wednesday, January 16 | 5:00PM - 7:00PM
Barrier Function in IBD
Room: Chamisa Ballroom 1

Speaker 3 of 6
Lora V. Hooper, University of Texas Southwestern Medical Center, USA
Interactions among the Microbiota, the Immune System and the Circadian Clock

Wednesday, January 16 | 5:00PM - 7:00PM
Barrier Function in IBD
Room: Chamisa Ballroom 1

Speaker 4 of 6
Andrew T. Gewirtz, Georgia State University / Frontiers, USA
Gut microbiota, Diet and Chronic Inflammation

Wednesday, January 16 | 5:00PM - 7:00PM
Barrier Function in IBD
Room: Chamisa Ballroom 1

Speaker 5 of 6
Pradipta Ghosh, University of California, San Diego, USA
Short Talk: Network-Based Approaches to Improve Precision and Prediction in IBD Therapeutics

Wednesday, January 16 | 5:00PM - 7:00PM
Barrier Function in IBD
Room: Chamisa Ballroom 1

Speaker 6 of 6
Jordi M. Lanis, University of Colorado Anschutz Medical Campus, USA
Short Talk: Contributions of Creatine Kinase to Mucosal Immune Responses in Murine Colitis

Wednesday, January 16 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2
No registration fees are used to fund alcohol served at this function.

Wednesday, January 16 | 7:30PM - 10:00PM
Poster Session 3
Room: Chamisa Ballroom 2


Thursday, January 17 | 7:00AM - 8:00AM
Breakfast
Room: Sagebrush Lobby & Cantina


Thursday, January 17 | 8:00AM - 11:00AM
Translational Opportunities (Bench to Bedside and Back Again
)

Room: Chamisa Ballroom 1

Speaker 1 of 8
* Judy H. Cho, Icahn School of Medicine at Mount Sinai, USA

Thursday, January 17 | 8:00AM - 11:00AM
Translational Opportunities (Bench to Bedside and Back Again
)

Room: Chamisa Ballroom 1

Speaker 2 of 8
Gary D. Wu, University of Pennsylvania, USA
Engineering the Gut Microbiome in IBD

Thursday, January 17 | 8:00AM - 11:00AM
Translational Opportunities (Bench to Bedside and Back Again
)

Room: Chamisa Ballroom 1

Speaker 3 of 8
Scott Snapper, Children`s Hospital Boston, USA
Identifying Novel Immune Therapeutics through Studying Rare Diseases

Thursday, January 17 | 8:00AM - 11:00AM
Translational Opportunities (Bench to Bedside and Back Again
)

Room: Chamisa Ballroom 1


Coffee Break

Thursday, January 17 | 8:00AM - 11:00AM
Translational Opportunities (Bench to Bedside and Back Again
)

Room: Chamisa Ballroom 1

Speaker 5 of 8
Gregory C. Gibson, Georgia Institute of Technology, USA
Integrative Genomics in Discriminating IBD Progression

Thursday, January 17 | 8:00AM - 11:00AM
Translational Opportunities (Bench to Bedside and Back Again
)

Room: Chamisa Ballroom 1

Speaker 6 of 8
Markus F. Neurath, University Hospital Erlangen, Germany
Bridging the Gap between IBD Pathogenesis and the Development of New Therapeutics

Thursday, January 17 | 8:00AM - 11:00AM
Translational Opportunities (Bench to Bedside and Back Again
)

Room: Chamisa Ballroom 1

Speaker 7 of 8
Dominic Boardman, University of British Columbia, Canada
Short Talk: Engineering Flagellin-Specific Regulatory T Cells to Restore Intestinal Homeostasis in IBD

Thursday, January 17 | 8:00AM - 11:00AM
Translational Opportunities (Bench to Bedside and Back Again
)

Room: Chamisa Ballroom 1

Speaker 8 of 8
Ting Fu, The Salk Institute, USA
Short Talk: Nutritional Modulation of Intestinal Innate Immunity by BA-FXR Axis

Thursday, January 17 | 11:00AM - 5:00PM
On Own for Lunch


Thursday, January 17 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Thursday, January 17 | 5:00PM - 6:45PM
New Technologies and Collaborations between Industry and Aca
demia

Room: Chamisa Ballroom 1

Speaker 1 of 4
* Clara Abraham, Yale University, USA

Thursday, January 17 | 5:00PM - 6:45PM
New Technologies and Collaborations between Industry and Aca
demia

Room: Chamisa Ballroom 1

Speaker 2 of 4
Scott Plevy, Janssen, USA
Restoration of Immune and Microbial Homeostasis by a Live Bacterial Therapeutic: Investigations into Mechanisms and Development of VE202

Thursday, January 17 | 5:00PM - 6:45PM
New Technologies and Collaborations between Industry and Aca
demia

Room: Chamisa Ballroom 1

Speaker 3 of 4
Chas Bountra, University of Oxford, UK
Big Data in Pharma-Academic Collaborations

Thursday, January 17 | 5:00PM - 6:45PM
New Technologies and Collaborations between Industry and Aca
demia

Room: Chamisa Ballroom 1

Speaker 4 of 4
Elizabeth Wiellette, Draper Laboratory, USA
Short Talk: A High-Throughput Microphysiologic System to Accurately Model Human Colon and Ileum

Thursday, January 17 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Chamisa Ballroom 1


Thursday, January 17 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2
No registration fees are used to fund alcohol served at this function.

Thursday, January 17 | 8:00PM - 11:00PM
Entertainment
Room: Chamisa Ballroom 2
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Thursday, January 17 | 8:00PM - 11:00PM
Cash Bar
Room: Chamisa Ballroom 2


Friday, January 18 | 10:24AM - 10:24AM
Departure


*Session Chair.